MACURE PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 35234748
Hejrevej 39, 2400 København NV
info@macurepharma.com
tel: 70204107
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 16 325.24 | 15 148.59 | 24 981.87 | 38 049.17 | 24 158.86 |
| Employee benefit expenses | -4 157.96 | -8 098.58 | -18 271.94 | -15 743.32 | -11 353.89 |
| Total depreciation | - 145.94 | - 137.24 | - 153.08 | - 137.84 | -1 252.84 |
| EBIT | 12 021.35 | 6 912.77 | 6 556.85 | 22 168.01 | 11 552.14 |
| Other financial income | 99.75 | 985.18 | 3 268.42 | ||
| Other financial expenses | - 205.30 | - 152.69 | - 172.76 | - 178.03 | -3 454.51 |
| Pre-tax profit | 11 816.05 | 6 760.08 | 6 483.85 | 22 975.15 | 11 366.04 |
| Income taxes | -2 628.34 | -1 502.46 | -1 436.15 | -5 080.61 | -2 575.67 |
| Net earnings | 9 187.71 | 5 257.62 | 5 047.70 | 17 894.55 | 8 790.38 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible rights | 1 308.51 | 1 263.10 | 2 206.60 | 2 571.28 | 4 960.35 |
| Intangible assets total | 1 308.51 | 1 263.10 | 2 206.60 | 2 571.28 | 4 960.35 |
| Tangible assets total | |||||
| Other receivables | 120.50 | 151.10 | 146.67 | 167.99 | 169.55 |
| Investments total | 120.50 | 151.10 | 146.67 | 167.99 | 169.55 |
| Long term receivables total | |||||
| Raw materials and consumables | 2 770.88 | 1 008.76 | |||
| Finished products/goods | 19 827.62 | 23 895.91 | 24 889.15 | 22 219.50 | 23 294.95 |
| Advance payments | 214.72 | ||||
| Inventories total | 19 827.62 | 23 895.91 | 24 889.15 | 24 990.38 | 24 518.42 |
| Current trade debtors | 19 174.22 | 23 954.44 | 52 805.50 | 40 220.01 | 28 790.36 |
| Current amounts owed by group member comp. | 10 866.99 | ||||
| Prepayments and accrued income | 160.16 | 1 001.00 | 763.55 | ||
| Current other receivables | 1 558.54 | 28 636.01 | 67 616.71 | ||
| Current deferred tax assets | 252.09 | 186.39 | 486.17 | 280.30 | |
| Short term receivables total | 19 334.39 | 25 765.07 | 63 858.88 | 70 343.20 | 97 450.92 |
| Cash and bank deposits | 3 455.06 | 6 476.43 | 9 383.60 | 18 487.56 | 43 174.08 |
| Cash and cash equivalents | 3 455.06 | 6 476.43 | 9 383.60 | 18 487.56 | 43 174.08 |
| Balance sheet total (assets) | 44 046.08 | 57 551.60 | 100 484.90 | 116 560.40 | 170 273.32 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Shares repurchased | 9 000.00 | 5 000.00 | 5 000.00 | 18 000.00 | 7 700.00 |
| Retained earnings | -4 073.32 | 114.39 | 372.02 | -12 580.29 | -2 385.74 |
| Profit of the financial year | 9 187.71 | 5 257.62 | 5 047.70 | 17 894.55 | 8 790.38 |
| Shareholders equity total | 14 194.39 | 10 452.01 | 10 499.71 | 23 394.26 | 14 184.63 |
| Provisions | 21.05 | ||||
| Non-current other liabilities | 133.44 | ||||
| Non-current liabilities total | 133.44 | ||||
| Current loans from credit institutions | 96.93 | ||||
| Advances received | 464.78 | 63.30 | |||
| Current trade creditors | 16 411.43 | 12 154.81 | 27 639.82 | 23 540.23 | 21 298.99 |
| Current owed to participating | 15.85 | 20.70 | 21 004.33 | 40.82 | 52.19 |
| Current owed to group member | 8 473.40 | 31 283.02 | 22 216.85 | 62 641.67 | 131 135.00 |
| Short-term deferred tax liabilities | 2 664.56 | 1 775.59 | 1 370.45 | 5 380.39 | 2 369.80 |
| Other non-interest bearing current liabilities | 2 120.46 | 1 865.48 | 17 753.73 | 1 098.26 | 1 072.48 |
| Accruals and deferred income | 11.50 | ||||
| Current liabilities total | 29 697.20 | 47 099.59 | 89 985.18 | 93 166.15 | 156 088.69 |
| Balance sheet total (liabilities) | 44 046.08 | 57 551.60 | 100 484.90 | 116 560.40 | 170 273.32 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.